GB201217635D0 - Use of short term insulin treatment to restore pancreatic function in type 2 diabetic patients who have become refractory through oral hypolgycaemic agents - Google Patents

Use of short term insulin treatment to restore pancreatic function in type 2 diabetic patients who have become refractory through oral hypolgycaemic agents

Info

Publication number
GB201217635D0
GB201217635D0 GBGB1217635.0A GB201217635A GB201217635D0 GB 201217635 D0 GB201217635 D0 GB 201217635D0 GB 201217635 A GB201217635 A GB 201217635A GB 201217635 D0 GB201217635 D0 GB 201217635D0
Authority
GB
United Kingdom
Prior art keywords
hypolgycaemic
oral
agents
type
short term
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Ceased
Application number
GBGB1217635.0A
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Individual
Original Assignee
Individual
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Individual filed Critical Individual
Priority to GBGB1217635.0A priority Critical patent/GB201217635D0/en
Publication of GB201217635D0 publication Critical patent/GB201217635D0/en
Ceased legal-status Critical Current

Links

GBGB1217635.0A 2012-10-02 2012-10-02 Use of short term insulin treatment to restore pancreatic function in type 2 diabetic patients who have become refractory through oral hypolgycaemic agents Ceased GB201217635D0 (en)

Priority Applications (1)

Application Number Priority Date Filing Date Title
GBGB1217635.0A GB201217635D0 (en) 2012-10-02 2012-10-02 Use of short term insulin treatment to restore pancreatic function in type 2 diabetic patients who have become refractory through oral hypolgycaemic agents

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
GBGB1217635.0A GB201217635D0 (en) 2012-10-02 2012-10-02 Use of short term insulin treatment to restore pancreatic function in type 2 diabetic patients who have become refractory through oral hypolgycaemic agents

Publications (1)

Publication Number Publication Date
GB201217635D0 true GB201217635D0 (en) 2012-11-14

Family

ID=47225568

Family Applications (1)

Application Number Title Priority Date Filing Date
GBGB1217635.0A Ceased GB201217635D0 (en) 2012-10-02 2012-10-02 Use of short term insulin treatment to restore pancreatic function in type 2 diabetic patients who have become refractory through oral hypolgycaemic agents

Country Status (1)

Country Link
GB (1) GB201217635D0 (en)

Similar Documents

Publication Publication Date Title
IL232251B (en) A pharmaceutical combination for use in the treatment of a diabetes type 2 patient
HK1208910A1 (en) Gpc3-targeted therapeutic agent for administration to patients for whom gpc3-targeted therapeutic agent therapy is effective gpc3 gpc3
HK1217088A1 (en) Use of microvesicles in diagnosis, prognosis, and treatment of medical diseases and conditions
HK1213192A1 (en) Methods and devices for the treatment of ocular diseases in human subjects
IL231536A (en) Indazole-3-carboxamides , pharmaceutical compositions comprising them and their use in the treatment of diseases
ZA201505849B (en) Composition of novel carbohydrate drug for treatment of human diseases
IN2015DN00544A (en)
MX356728B (en) Pharmaceutical combination for use in the treatment of diabetes type 2.
IN2015DN03219A (en)
EP2909209A4 (en) 2'-cyano substituted nucleoside derivatives and methods of use thereof for treatment of viral diseases
EP2729148A4 (en) Compositions and methods for treatment of symptoms in parkinson's disease patients
PH12013500892A1 (en) Composition for use in the prevention and/or treatment of skin conditions and skin diseases
EP2875158A4 (en) Use of microvesicles in diagnosis, prognosis, and treatment of medical diseases and conditions
EP3628326C0 (en) Methods and materials for treatment of pompe's disease
SI2691109T1 (en) Prevention of hypoglycaemia in diabetes mellitus type 2 patients
ZA201502290B (en) 2-phenyl-5-heterocyclyl-tetrahydro-2h-pyran-3-amine compounds for use in the treatment of diabetes and ist associated disorders
SG11201504447XA (en) Novel pharmaceutical formulations and their use in the treatment of periodontal disease
ZA201502332B (en) Medicinal treatment of dermal diseases in companion animals with norketotifen
EP2707486A4 (en) Diagnosis and treatment of friedreich's ataxia
EP2857030A4 (en) Use of composition in preparing health care products or medicines for preventing and treating allergic diseases
EP2714137A4 (en) A tunic intended to be worn by a patient undergoing infusion therapy, for use particularly by children
GB201217635D0 (en) Use of short term insulin treatment to restore pancreatic function in type 2 diabetic patients who have become refractory through oral hypolgycaemic agents
PL2852400T3 (en) An insulin analogue or its pharmaceutically acceptable salt, pharmaceutical composition with prolonged therapeutic effect, use of the insulin analogue, dosage method and method of treatment of diabetes
GB201304462D0 (en) Therapeutic vaccine for treatment of type 2 diabetes and impaired glucose tolerance
UA53217U (en) Mask for therapy and general health improvement

Legal Events

Date Code Title Description
AT Applications terminated before publication under section 16(1)